Premium
British HIV Association guidelines for the treatment of TB/HIV coinfection 2011
Author(s) -
Pozniak AL,
Coyne KM,
Miller RF,
Lipman MCI,
Freedman AR,
Ormerod LP,
Johnson MA,
Collins S,
Lucas SB
Publication year - 2011
Publication title -
hiv medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.53
H-Index - 79
eISSN - 1468-1293
pISSN - 1464-2662
DOI - 10.1111/j.1468-1293.2011.00954.x
Subject(s) - medicine , immune reconstitution inflammatory syndrome , tuberculosis , coinfection , isoniazid , drug resistant tuberculosis , latent tuberculosis , intensive care medicine , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , viral load , mycobacterium tuberculosis , pathology
1.0 Summary of guidelines 2.0 Introduction 3.0 Aims of TB treatment 4.0 Diagnostic tests 5.0 Type and duration of TB treatment 6.0 Drug–drug interactions 7.0 Overlapping toxicity profiles of antiretrovirals and TB therapy 8.0 Drug absorption 9.0 When to start HAART 10.0 Directly observed therapy (DOT) 11.0 Management of relapse, treatment failure and drug resistance 12.0 Pregnancy and breast-feeding 13.0 Treatment of latent TB infection – HAART, anti-tuberculosis drugs or both? 14.0 Immune reconstitution inflammatory syndrome (IRIS) 15.0 Prevention and control of transmission 16.0 Death and clinico-pathological audit 17.0 Tables 18.0 Key points 19.0 References